Together with Almac Group’s Board of Directors, Dennise is responsible for all aspects of the pharmaceutical company’s operations, marketing and governance across its sites throughout the UK and Europe.

Dennise is a highly successful, respected and inspiring Executive Business Leader, with an extensive career within the pharmaceutical industry. Most recently Dennise held the position of Country Manager, leading the Irish affiliate of IPSEN Pharmaceuticals and was responsible for all aspects of the business. Prior to this Dennise also held CEO/MD and senior leadership roles with Pfizer, Hospira, Zeneus, Viatris and other pharmaceutical companies both in Ireland and Europe.

Dennise is also very highly respected academically and remains on the invite list as a guest lecturer within the National Universities of Ireland having previously lectured part-time within their network.

Based in Craigavon, Northern Ireland, Martin is responsible for overseeing and developing the financial and operational aspects of the global Galen organisation as well as having involvement in key business projects as a member of the Galen Leadership Team.

Martin studied at the University of Stirling, is a Fellow of the Chartered Institute of Management Accountants and has over 20 years’ experience in finance. 

Based in Copenhagen, Denmark, Simon has responsibility for leading commercial activities across the Nordic region, including management of sales and marketing activities and supply chain/logistics.

Previously Simon has held a number of senior sales and marketing positions including business development where he was responsible for the strategic identification, evaluation & delivery of growth opportunities, such as in-licensing of new products & expansion to new international markets.

Simon studied Pharmacy at Aston University in England and has over 32 years’ experience in the pharmaceutical industry.

Based in Craigavon, Northern Ireland, Paul has responsibility for leading sales and marketing activities across the UK and Ireland, with a particular focus on positioning Penthrox as the number one analgesic in emergency departments and ensuring Galen’s Trustsaver brands provide a cost effective solution for the UK and Ireland health service.

Paul studied at St John’s University York and has over 30 years’ experience in the industry.

Based in Craigavon, Northern Ireland, Johnny is responsible for the strategic identification, evaluation & delivery of growth opportunities, such as acquisitions, in-licensing of new products, out-licensing of Galen’s products as well as expansion into new international markets.  In addition, Johnny oversees the alliance management function within Galen.

Previously Johnny spent time in both operational and business development roles within contract research and pharmaceutical companies.

Johnny studied Physiology at the University of Glasgow and has 18 years’ experience in the industry.

Based in Craigavon, Northern Ireland, Louise is responsible for commercial operations across the Galen business globally. This includes achieving business targets for all products by supporting the sales and marketing divisions, driving sales of non-promoted portfolio products, and being responsible for logistics and supply across all Galen sites and distribution partners. 

Louise has worked in Galen for over 25 years in various roles.